[
  {
    "title": "Biogen, Eisai : CHMP Reaffirms Backing of Leqembi Alzheimer's Drug",
    "published": 1740737298,
    "day_prices": {
      "2025-02-28T14:30:00+00:00": 141.05999755859375,
      "2025-02-28T15:30:00+00:00": 138.67999267578125,
      "2025-02-28T16:30:00+00:00": 138.60000610351562,
      "2025-02-28T17:30:00+00:00": 139.24000549316406,
      "2025-02-28T18:30:00+00:00": 139.3800048828125,
      "2025-02-28T19:30:00+00:00": 139.36500549316406,
      "2025-02-28T20:30:00+00:00": 139.88499450683594
    },
    "sentiment": 0.7868469953536987
  },
  {
    "title": "Biogen : The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer\u2019s Disease",
    "published": 1740731444,
    "day_prices": {
      "2025-02-28T14:30:00+00:00": 141.05999755859375,
      "2025-02-28T15:30:00+00:00": 138.67999267578125,
      "2025-02-28T16:30:00+00:00": 138.60000610351562,
      "2025-02-28T17:30:00+00:00": 139.24000549316406,
      "2025-02-28T18:30:00+00:00": 139.3800048828125,
      "2025-02-28T19:30:00+00:00": 139.36500549316406,
      "2025-02-28T20:30:00+00:00": 139.88499450683594
    },
    "sentiment": 0.9085825085639954
  },
  {
    "title": "EU regulator not updating opinion on Eisai-Biogen's Alzheimer's drug",
    "published": 1740729289,
    "day_prices": {
      "2025-02-28T14:30:00+00:00": 141.05999755859375,
      "2025-02-28T15:30:00+00:00": 138.67999267578125,
      "2025-02-28T16:30:00+00:00": 138.60000610351562,
      "2025-02-28T17:30:00+00:00": 139.24000549316406,
      "2025-02-28T18:30:00+00:00": 139.3800048828125,
      "2025-02-28T19:30:00+00:00": 139.36500549316406,
      "2025-02-28T20:30:00+00:00": 139.88499450683594
    },
    "sentiment": 0.7941930890083313
  },
  {
    "title": "Why Novartis Remains A 'Buy' After Beating Expectations Again",
    "published": 1740650974,
    "day_prices": {
      "2025-02-27T14:30:00+00:00": 140.05999755859375,
      "2025-02-27T15:30:00+00:00": 141.39999389648438,
      "2025-02-27T16:30:00+00:00": 140.8800048828125,
      "2025-02-27T17:30:00+00:00": 141.22000122070312,
      "2025-02-27T18:30:00+00:00": 140.7899932861328,
      "2025-02-27T19:30:00+00:00": 140.89999389648438,
      "2025-02-27T20:30:00+00:00": 139.9600067138672
    },
    "sentiment": 0.7849723100662231
  },
  {
    "title": "Biogen Inc. (BIIB): Among the Stocks That Will Go to The Moon According to Analysts",
    "published": 1740503974,
    "day_prices": {
      "2025-02-25T14:30:00+00:00": 140.00999450683594,
      "2025-02-25T15:30:00+00:00": 145.17999267578125,
      "2025-02-25T16:30:00+00:00": 143.1649932861328,
      "2025-02-25T17:30:00+00:00": 143.88999938964844,
      "2025-02-25T18:30:00+00:00": 143.4600067138672,
      "2025-02-25T19:30:00+00:00": 143.00999450683594,
      "2025-02-25T20:30:00+00:00": 143.24000549316406
    },
    "sentiment": 0.913234531879425
  },
  {
    "title": "NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects",
    "published": 1740418773,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 141.3300018310547,
      "2025-02-24T15:30:00+00:00": 142.8509063720703,
      "2025-02-24T16:30:00+00:00": 141.02000427246094,
      "2025-02-24T17:30:00+00:00": 140.7899932861328,
      "2025-02-24T18:30:00+00:00": 140.64500427246094,
      "2025-02-24T19:30:00+00:00": 140.55999755859375,
      "2025-02-24T20:30:00+00:00": 140.6199951171875
    },
    "sentiment": 0.8000811338424683
  },
  {
    "title": "Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency",
    "published": 1740405840,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 141.3300018310547,
      "2025-02-24T15:30:00+00:00": 142.8509063720703,
      "2025-02-24T16:30:00+00:00": 141.02000427246094,
      "2025-02-24T17:30:00+00:00": 140.7899932861328,
      "2025-02-24T18:30:00+00:00": 140.64500427246094,
      "2025-02-24T19:30:00+00:00": 140.55999755859375,
      "2025-02-24T20:30:00+00:00": 140.6199951171875
    },
    "sentiment": 0.8951395750045776
  },
  {
    "title": "Ionis Pharmaceuticals Reports Strong Q4 Earnings After Recent FDA Approval",
    "published": 1739976042,
    "day_prices": {
      "2025-02-19T14:30:00+00:00": 135.9499969482422,
      "2025-02-19T15:30:00+00:00": 136.92999267578125,
      "2025-02-19T16:30:00+00:00": 135.9499969482422,
      "2025-02-19T17:30:00+00:00": 135.1199951171875,
      "2025-02-19T18:30:00+00:00": 135.84979248046875,
      "2025-02-19T19:30:00+00:00": 136.13999938964844,
      "2025-02-19T20:30:00+00:00": 136.2100067138672
    },
    "sentiment": 0.9556342363357544
  },
  {
    "title": "We Think Biogen's (NASDAQ:BIIB) Healthy Earnings Might Be Conservative",
    "published": 1739963545,
    "day_prices": {
      "2025-02-19T14:30:00+00:00": 135.9499969482422,
      "2025-02-19T15:30:00+00:00": 136.92999267578125,
      "2025-02-19T16:30:00+00:00": 135.9499969482422,
      "2025-02-19T17:30:00+00:00": 135.1199951171875,
      "2025-02-19T18:30:00+00:00": 135.84979248046875,
      "2025-02-19T19:30:00+00:00": 136.13999938964844,
      "2025-02-19T20:30:00+00:00": 136.2100067138672
    },
    "sentiment": 0.953611433506012
  },
  {
    "title": "Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments",
    "published": 1739883600,
    "day_prices": {
      "2025-02-18T14:30:00+00:00": 138.00999450683594,
      "2025-02-18T15:30:00+00:00": 137.11000061035156,
      "2025-02-18T16:30:00+00:00": 136.72000122070312,
      "2025-02-18T17:30:00+00:00": 136.1199951171875,
      "2025-02-18T18:30:00+00:00": 136.14999389648438,
      "2025-02-18T19:30:00+00:00": 136.5,
      "2025-02-18T20:30:00+00:00": 137.1199951171875
    },
    "sentiment": 0.7611865997314453
  },
  {
    "title": "Stoke Therapeutics and Biogen in pact for treatment for severe form of childhood epilepsy",
    "published": 1739871900,
    "day_prices": {
      "2025-02-18T14:30:00+00:00": 138.00999450683594,
      "2025-02-18T15:30:00+00:00": 137.11000061035156,
      "2025-02-18T16:30:00+00:00": 136.72000122070312,
      "2025-02-18T17:30:00+00:00": 136.1199951171875,
      "2025-02-18T18:30:00+00:00": 136.14999389648438,
      "2025-02-18T19:30:00+00:00": 136.5,
      "2025-02-18T20:30:00+00:00": 137.1199951171875
    },
    "sentiment": 0.7594791054725647
  },
  {
    "title": "Parnassus Value Equity Fund Q4 And 2024 Annual Investment Commentary",
    "published": 1739780400,
    "day_prices": {},
    "sentiment": 0.9255211353302002
  },
  {
    "title": "Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts",
    "published": 1739475019,
    "day_prices": {
      "2025-02-13T14:30:00+00:00": 132.60000610351562,
      "2025-02-13T15:30:00+00:00": 134.27000427246094,
      "2025-02-13T16:30:00+00:00": 136.66000366210938,
      "2025-02-13T17:30:00+00:00": 136.375,
      "2025-02-13T18:30:00+00:00": 137.71499633789062,
      "2025-02-13T19:30:00+00:00": 138.93499755859375,
      "2025-02-13T20:30:00+00:00": 138.1699981689453
    },
    "sentiment": 0.765851616859436
  },
  {
    "title": "Biogen Hammered As Lackluster Guidance Drags On Fourth-Quarter Beat",
    "published": 1739377129,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 136.7550048828125,
      "2025-02-12T15:30:00+00:00": 130.41000366210938,
      "2025-02-12T16:30:00+00:00": 131.92999267578125,
      "2025-02-12T17:30:00+00:00": 133.24000549316406,
      "2025-02-12T18:30:00+00:00": 131.10400390625,
      "2025-02-12T19:30:00+00:00": 131.1699981689453,
      "2025-02-12T20:30:00+00:00": 132.64999389648438
    },
    "sentiment": 0.9642264246940613
  },
  {
    "title": "Biogen Inc. (BIIB) Q4 2024 Earnings Call Transcript",
    "published": 1739364090,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 136.7550048828125,
      "2025-02-12T15:30:00+00:00": 130.41000366210938,
      "2025-02-12T16:30:00+00:00": 131.92999267578125,
      "2025-02-12T17:30:00+00:00": 133.24000549316406,
      "2025-02-12T18:30:00+00:00": 131.10400390625,
      "2025-02-12T19:30:00+00:00": 131.1699981689453,
      "2025-02-12T20:30:00+00:00": 132.64999389648438
    },
    "sentiment": 0.9115504026412964
  },
  {
    "title": "Biogen Inc. 2024 Q4 - Results - Earnings Call Presentation",
    "published": 1739350342,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 136.7550048828125,
      "2025-02-12T15:30:00+00:00": 130.41000366210938,
      "2025-02-12T16:30:00+00:00": 131.92999267578125,
      "2025-02-12T17:30:00+00:00": 133.24000549316406,
      "2025-02-12T18:30:00+00:00": 131.10400390625,
      "2025-02-12T19:30:00+00:00": 131.1699981689453,
      "2025-02-12T20:30:00+00:00": 132.64999389648438
    },
    "sentiment": 0.9343756437301636
  },
  {
    "title": "Market darlings Robinhood, Reddit and Applovin deliver earnings after the close",
    "published": 1739340135,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 136.7550048828125,
      "2025-02-12T15:30:00+00:00": 130.41000366210938,
      "2025-02-12T16:30:00+00:00": 131.92999267578125,
      "2025-02-12T17:30:00+00:00": 133.24000549316406,
      "2025-02-12T18:30:00+00:00": 131.10400390625,
      "2025-02-12T19:30:00+00:00": 131.1699981689453,
      "2025-02-12T20:30:00+00:00": 132.64999389648438
    },
    "sentiment": 0.608445942401886
  },
  {
    "title": "ClearBridge Global Value Improvers Strategy Q4 2024 Commentary",
    "published": 1739150100,
    "day_prices": {
      "2025-02-10T14:30:00+00:00": 141.6300048828125,
      "2025-02-10T15:30:00+00:00": 141.5399932861328,
      "2025-02-10T16:30:00+00:00": 140.4600067138672,
      "2025-02-10T17:30:00+00:00": 140.3000030517578,
      "2025-02-10T18:30:00+00:00": 140.5399932861328,
      "2025-02-10T19:30:00+00:00": 140.88999938964844,
      "2025-02-10T20:30:00+00:00": 141.5500030517578
    },
    "sentiment": 0.8980556130409241
  },
  {
    "title": "Biogen Inc. stock underperforms Monday when compared to competitors",
    "published": 1738602420,
    "day_prices": {
      "2025-02-03T14:30:00+00:00": 142.5,
      "2025-02-03T15:30:00+00:00": 144.38999938964844,
      "2025-02-03T16:30:00+00:00": 143.61000061035156,
      "2025-02-03T17:30:00+00:00": 142.88999938964844,
      "2025-02-03T18:30:00+00:00": 142.3300018310547,
      "2025-02-03T19:30:00+00:00": 142.5399932861328,
      "2025-02-03T20:30:00+00:00": 142.15499877929688
    },
    "sentiment": 0.8979841470718384
  },
  {
    "title": "ClearBridge Growth ESG Portfolios Q4 2024 Commentary",
    "published": 1743123300,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 140.60000610351562,
      "2025-03-28T14:30:00+00:00": 139.72000122070312,
      "2025-03-28T15:30:00+00:00": 139.1925048828125,
      "2025-03-28T16:30:00+00:00": 138.9600067138672,
      "2025-03-28T17:30:00+00:00": 138.75,
      "2025-03-28T18:30:00+00:00": 139.3699951171875,
      "2025-03-28T19:30:00+00:00": 139.02000427246094
    },
    "sentiment": 0.9503342509269714
  },
  {
    "title": "Biogen: Balancing Risks And Opportunities",
    "published": 1743092089,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 142.77000427246094,
      "2025-03-27T14:30:00+00:00": 142.02999877929688,
      "2025-03-27T15:30:00+00:00": 141.24000549316406,
      "2025-03-27T16:30:00+00:00": 140.23500061035156,
      "2025-03-27T17:30:00+00:00": 139.9199981689453,
      "2025-03-27T18:30:00+00:00": 140.1699981689453,
      "2025-03-27T19:30:00+00:00": 140.85000610351562
    },
    "sentiment": 0.8790386915206909
  },
  {
    "title": "Biogen Inc. stock outperforms competitors on strong trading day",
    "published": 1743008820,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 139.19000244140625,
      "2025-03-26T14:30:00+00:00": 140.9324951171875,
      "2025-03-26T15:30:00+00:00": 140.0749969482422,
      "2025-03-26T16:30:00+00:00": 139.8800048828125,
      "2025-03-26T17:30:00+00:00": 140.6999969482422,
      "2025-03-26T18:30:00+00:00": 141.32000732421875,
      "2025-03-26T19:30:00+00:00": 142.49000549316406
    },
    "sentiment": 0.9441573023796082
  },
  {
    "title": "BIOGEN : TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS MAY 1, 2025",
    "published": 1742919254,
    "day_prices": {
      "2025-03-25T13:30:00+00:00": 142.25,
      "2025-03-25T14:30:00+00:00": 140.38999938964844,
      "2025-03-25T15:30:00+00:00": 140.47000122070312,
      "2025-03-25T16:30:00+00:00": 140.78500366210938,
      "2025-03-25T17:30:00+00:00": 140.61000061035156,
      "2025-03-25T18:30:00+00:00": 139.85000610351562,
      "2025-03-25T19:30:00+00:00": 138.8699951171875
    },
    "sentiment": 0.9346489310264587
  },
  {
    "title": "3 Value Stocks Walking a Fine Line",
    "published": 1742821347,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 141.60000610351562,
      "2025-03-24T14:30:00+00:00": 142.05999755859375,
      "2025-03-24T15:30:00+00:00": 142.8300018310547,
      "2025-03-24T16:30:00+00:00": 143.55999755859375,
      "2025-03-24T17:30:00+00:00": 143.00999450683594,
      "2025-03-24T18:30:00+00:00": 141.02999877929688,
      "2025-03-24T19:30:00+00:00": 141.66000366210938
    },
    "sentiment": 0.7282007336616516
  },
  {
    "title": "Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square",
    "published": 1742815800,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 141.60000610351562,
      "2025-03-24T14:30:00+00:00": 142.05999755859375,
      "2025-03-24T15:30:00+00:00": 142.8300018310547,
      "2025-03-24T16:30:00+00:00": 143.55999755859375,
      "2025-03-24T17:30:00+00:00": 143.00999450683594,
      "2025-03-24T18:30:00+00:00": 141.02999877929688,
      "2025-03-24T19:30:00+00:00": 141.66000366210938
    },
    "sentiment": 0.5513293147087097
  },
  {
    "title": "Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks",
    "published": 1742461970,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 141.13999938964844,
      "2025-03-20T14:30:00+00:00": 142.38999938964844,
      "2025-03-20T15:30:00+00:00": 141.25999450683594,
      "2025-03-20T16:30:00+00:00": 141.7550048828125,
      "2025-03-20T17:30:00+00:00": 141.7899932861328,
      "2025-03-20T18:30:00+00:00": 141.8699951171875,
      "2025-03-20T19:30:00+00:00": 141.60000610351562
    },
    "sentiment": 0.9550654292106628
  },
  {
    "title": "Biogen Inc. (BIIB): Among the Most Undervalued Biotech Stocks to Invest In",
    "published": 1742394645,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 143.08999633789062,
      "2025-03-19T14:30:00+00:00": 142.61000061035156,
      "2025-03-19T15:30:00+00:00": 141.61000061035156,
      "2025-03-19T16:30:00+00:00": 142.02499389648438,
      "2025-03-19T17:30:00+00:00": 141.42999267578125,
      "2025-03-19T18:30:00+00:00": 141.44830322265625,
      "2025-03-19T19:30:00+00:00": 142.0500030517578
    },
    "sentiment": 0.4985310137271881
  },
  {
    "title": "Health Canada approves Biogen\u2019s Skyclarys for Friedreich\u2019s ataxia",
    "published": 1742297727,
    "day_prices": {
      "2025-03-18T13:30:00+00:00": 143.1699981689453,
      "2025-03-18T14:30:00+00:00": 144.76499938964844,
      "2025-03-18T15:30:00+00:00": 145.32000732421875,
      "2025-03-18T16:30:00+00:00": 143.89999389648438,
      "2025-03-18T17:30:00+00:00": 143.58580017089844,
      "2025-03-18T18:30:00+00:00": 142.98500061035156,
      "2025-03-18T19:30:00+00:00": 143.13999938964844
    },
    "sentiment": 0.504037082195282
  },
  {
    "title": "Biogen Canada's Skyclarys Approved By Health Canada To Treat Friedreich's Ataxia In Patients 16 Years Of Age And Older",
    "published": 1742195896,
    "day_prices": {
      "2025-03-17T13:30:00+00:00": 140.0500030517578,
      "2025-03-17T14:30:00+00:00": 141.32000732421875,
      "2025-03-17T15:30:00+00:00": 141.02499389648438,
      "2025-03-17T16:30:00+00:00": 141.7550048828125,
      "2025-03-17T17:30:00+00:00": 142.1199951171875,
      "2025-03-17T18:30:00+00:00": 142.99000549316406,
      "2025-03-17T19:30:00+00:00": 143.0050048828125
    },
    "sentiment": 0.8147182464599609
  },
  {
    "title": "Eli Lilly Reverses Its Recent Upswing On Broader Market Woes. Is It A Sell?",
    "published": 1741961322,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 139.2100067138672,
      "2025-03-14T14:30:00+00:00": 139.7550048828125,
      "2025-03-14T15:30:00+00:00": 140.02499389648438,
      "2025-03-14T16:30:00+00:00": 140.11000061035156,
      "2025-03-14T17:30:00+00:00": 139.80999755859375,
      "2025-03-14T18:30:00+00:00": 139.46499633789062,
      "2025-03-14T19:30:00+00:00": 139.47999572753906
    },
    "sentiment": 0.5089832544326782
  },
  {
    "title": "BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant",
    "published": 1741795920,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 142.00999450683594,
      "2025-03-12T14:30:00+00:00": 142.33999633789062,
      "2025-03-12T15:30:00+00:00": 141.10000610351562,
      "2025-03-12T16:30:00+00:00": 141.07000732421875,
      "2025-03-12T17:30:00+00:00": 141.27999877929688,
      "2025-03-12T18:30:00+00:00": 140.99000549316406,
      "2025-03-12T19:30:00+00:00": 140.8000030517578
    },
    "sentiment": 0.7842369675636292
  },
  {
    "title": "Biogen : to Participate in the Stifel 2025 Virtual CNS Forum",
    "published": 1741711163,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 151.1300048828125,
      "2025-03-11T14:30:00+00:00": 145.0399932861328,
      "2025-03-11T15:30:00+00:00": 143.4949951171875,
      "2025-03-11T16:30:00+00:00": 142.8800048828125,
      "2025-03-11T17:30:00+00:00": 142.80999755859375,
      "2025-03-11T18:30:00+00:00": 143.4425048828125,
      "2025-03-11T19:30:00+00:00": 143.7899932861328
    },
    "sentiment": 0.8301234245300293
  },
  {
    "title": "Biogen Inc. (BIIB) Management presents at Leerink Global Healthcare Conference 2025 (Transcript)",
    "published": 1741629757,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 150.2899932861328,
      "2025-03-10T14:30:00+00:00": 156.24000549316406,
      "2025-03-10T15:30:00+00:00": 156.4149932861328,
      "2025-03-10T16:30:00+00:00": 154.9499969482422,
      "2025-03-10T17:30:00+00:00": 155.97000122070312,
      "2025-03-10T18:30:00+00:00": 154.97999572753906,
      "2025-03-10T19:30:00+00:00": 152.75
    },
    "sentiment": 0.93522047996521
  },
  {
    "title": "Tariffs Send Investors to Safety of Food, Drug and Utility Stocks",
    "published": 1741107750,
    "day_prices": {
      "2025-03-04T14:30:00+00:00": 143.41000366210938,
      "2025-03-04T15:30:00+00:00": 147.32000732421875,
      "2025-03-04T16:30:00+00:00": 144.22500610351562,
      "2025-03-04T17:30:00+00:00": 143.77000427246094,
      "2025-03-04T18:30:00+00:00": 142.97000122070312,
      "2025-03-04T19:30:00+00:00": 141.99000549316406,
      "2025-03-04T20:30:00+00:00": 142.0500030517578
    },
    "sentiment": 0.8728858232498169
  },
  {
    "title": "Biogen Inc. (BIIB) CEO Chris Viehbacher presents at TD Cowen 45th Annual Health Care Conference (Transcript)",
    "published": 1741026575,
    "day_prices": {
      "2025-03-03T14:30:00+00:00": 140.0749969482422,
      "2025-03-03T15:30:00+00:00": 141.5500030517578,
      "2025-03-03T16:30:00+00:00": 141.66400146484375,
      "2025-03-03T17:30:00+00:00": 142.00999450683594,
      "2025-03-03T18:30:00+00:00": 141.35000610351562,
      "2025-03-03T19:30:00+00:00": 141.52000427246094,
      "2025-03-03T20:30:00+00:00": 141.97999572753906
    },
    "sentiment": 0.9335558414459229
  },
  {
    "title": "Do You Own 15 Stocks Morningstar Calls The Top 'Wealth Destroyers?'",
    "published": 1740988856,
    "day_prices": {
      "2025-03-03T14:30:00+00:00": 140.0749969482422,
      "2025-03-03T15:30:00+00:00": 141.5500030517578,
      "2025-03-03T16:30:00+00:00": 141.66400146484375,
      "2025-03-03T17:30:00+00:00": 142.00999450683594,
      "2025-03-03T18:30:00+00:00": 141.35000610351562,
      "2025-03-03T19:30:00+00:00": 141.52000427246094,
      "2025-03-03T20:30:00+00:00": 141.97999572753906
    },
    "sentiment": 0.9420490860939026
  }
]